Arrowhead Listing Upgraded to NASDAQ Global Select Market

[at noodls] – PASADENA, Calif. – February 21, 2014 – Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received notice that the … more

View todays social media effects on ARWR

View the latest stocks trending across Twitter. Click to view dashboard

See who Arrowhead is hiring next, click here to view